White label – Pompe disease - ClinicalTrials.eu

A study evaluating the efficacy and safety of inavolisib and enzalutamide in patients with metastatic castration-resistant prostate cancer

Recruiting

2 1 1 1
Investigated Drugs:
A study to compare the efficacy and safety of AVT29 and aflibercept in patients with diabetic macular edema

Recruiting

3 1 1 1
Investigated Drugs:
- Aflibercept
Study of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.

Recruiting

1 1 1 1
Investigated Drugs:
Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

Recruiting

3 1 1 1
Investigated Diseases:
- Hypothyroidism
- Chronic kidney disease
Investigated Drugs:
- Levothyroxine
Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

Recruiting

2 1 1 1
Investigated Diseases:
- Monogenic diabetes
Investigated Drugs:
- Glimepiride
Evaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster

Recruiting

3 1 1 1
Investigated Diseases:
- Herpes zoster
Investigated Drugs:
- Recombinant Varicella Zoster Virus Glycoprotein E
A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

Recruiting

2 1 1
Investigated Diseases:
- Cardiac function disturbance postoperative
- Acute kidney injury
Investigated Drugs:
- R2R01
- Sodium Chloride
Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

Recruiting

3 1 1 1
Investigated Diseases:
- Pyelonephritis
Investigated Drugs:
A study comparing different zinc doses for the treatment of Wilson disease in healthy participants.

Recruiting

2 1 1
Investigated Diseases:
- Hepato-lenticular degeneration
Investigated Drugs:
- Copper (64Cu) Chloride
- ZINC
Using 68Ga-FAPI-46 imaging to detect fibrosis in patients with inflammatory diseases such as Crohn’s disease, ulcerative colitis, systemic sclerosis, and lung fibrosis.

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies